KRO vs UTHR · rev $1.89B vs P/E 20, rev $1.56B
Kronos Worldwide Inc (KRO) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Kronos Worldwide Inc (KRO) is a specialty chemicals company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported KRO revenue for 2024-12-31 was $1.89B. Net income was $86.2M. Revenue was up 13.2% from 2023-12-31 to 2024-12-31. KRO currently screens at market cap $813.4M.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
KRO currently screens at market cap $813.4M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the KRO and UTHR stock pages for the full models.
Not investment advice.